Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.

@article{Paireder2017ImpactOS,
  title={Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.},
  author={Matthias Paireder and Reza Asari and Ivan Kristo and Erwin Rieder and Dietmar Tamandl and Ahmed Ba-Ssalamah and Sebastian F Schoppmann},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2017},
  volume={43 2},
  pages={478-484}
}
BACKGROUND Nutritional status and body composition parameters such as sarcopenia are important risk factors for impaired outcome in patients with esophageal cancer. This study was conducted to evaluate the effect of sarcopenia on long-term outcome after esophageal resection following neoadjuvant treatment. METHODS Skeletal muscle index (SMI) and body composition parameters were measured in patients receiving neoadjuvant treatment for locally advanced esophageal cancer. Endpoints included… CONTINUE READING